STOCK TITAN

Processa Pharmaceuticals (PCSA) CEO Ng Converts 1,600 Restricted Shares to Common

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Processa Pharmaceuticals, Inc. director and CEO George K. Ng reported the distribution of a time-based restricted stock award. On August 8, 2026, 1,600 shares of restricted stock converted into 1,600 shares of common stock, leaving him with 17,092 directly held common shares and 19,624 restricted shares. He also reports options to acquire 30,720 common shares at an exercise price of $4.96 per share and additional indirect common stock holdings through related entities. Certain reported share amounts reflect a 1-for-25 reverse stock split effective December 17, 2025.

Positive

  • None.

Negative

  • None.
Insider Ng George K
Role Chief Executive Officer
Type Security Shares Price Value
Exercise Restricted Stock F1, F3 1,600 $0.00 $0.00
Exercise Common Stock F1 1,600 -- --
holding Stock Options (Right to Buy) F2, F3 -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Restricted Stock — 19,624 shares (Direct); Common Stock — 17,092 shares (Direct); Stock Options (Right to Buy) — 30,720 shares (Direct); Common Stock — 3,488 shares (Indirect, George Ng IRRA FOB George Ng); Common Stock — 800 shares (Indirect, Ng Cha Family Trust)
Footnotes (3)
  1. F1. Distribution of time-based service award.
  2. F2. Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years.
  3. F3. Reflects the 1-for-25 reverse stock split effected by the Issuer on December 17, 2025.
Restricted shares converted 1,600 shares Restricted stock converted to common on August 8, 2026
Direct common shares held 17,092 shares Direct common stock ownership following August 8, 2026 transaction
Restricted stock held 19,624 shares Restricted stock balance following derivative exercise/conversion
Options underlying shares 30,720 shares Underlying common shares for stock options held directly
Option exercise price $4.96 per share Exercise price of stock options (right to buy) on common stock
Indirect holding (IRRA) 3,488 shares Common stock held indirectly as “George Ng IRRA FOB George Ng”
Indirect holding (Family Trust) 800 shares Common stock held indirectly through Ng Cha Family Trust
Reverse stock split ratio 1-for-25 Reverse stock split effective December 17, 2025, reflected in share counts
Restricted Stock financial
"security_title: "Restricted Stock""
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
Stock Options (Right to Buy) financial
"security_title: "Stock Options (Right to Buy)""
time-based service award financial
"Distribution of time-based service award."
reverse stock split financial
"Reflects the 1-for-25 reverse stock split effected by the Issuer"
A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.
indirect ownership financial
"ownership_type: "indirect" with nature_of_ownership descriptions"

FAQ

What transaction did Processa (PCSA) CEO George K. Ng report on August 8, 2026?

George K. Ng reported the distribution of a time-based restricted stock award, in which 1,600 restricted shares converted into 1,600 shares of common stock on August 8, 2026, as part of his equity compensation.

How many Processa (PCSA) common shares does George K. Ng hold directly after this filing?

After the August 8, 2026 transaction, George K. Ng directly holds 17,092 shares of common stock. In addition, he reports 19,624 shares of restricted stock and separate indirect holdings through related entities.

What restricted stock and option positions does George K. Ng have in Processa (PCSA)?

George K. Ng reports 19,624 shares of restricted stock following the distribution and stock options covering 30,720 underlying common shares with an exercise price of $4.96 per share, vesting over three years from the grant date.

What is the exercise price and size of George K. Ng’s Processa (PCSA) stock options?

He reports stock options with an exercise price of $4.96 per share, representing 30,720 underlying shares of Processa common stock, with one-third vesting on the first anniversary of grant and the remainder vesting ratably over the next two years.

Does George K. Ng have indirect holdings of Processa (PCSA) common stock?

Yes. The filing lists indirect ownership of 3,488 shares of common stock described as “George Ng IRRA FOB George Ng” and an additional 800 shares held indirectly through the Ng Cha Family Trust.

How did Processa’s 1-for-25 reverse stock split affect this Form 4 for PCSA?

A footnote states that reported amounts reflect a 1-for-25 reverse stock split effected on December 17, 2025. This means share counts in the Form 4 are presented after adjustment for that reverse split.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ng George K

(Last)(First)(Middle)
C/O PROCESSA PHARMACEUTICALS, INC.
601 21ST STREET SUITE 300

(Street)
VERO BEACH FLORIDA 32960

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Processa Pharmaceuticals, Inc. [ PCSA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/08/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/08/2026M1,600A(1)17,092D
Common Stock3,488IGeorge Ng IRRA FOB George Ng
Common Stock800INg Cha Family Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock$008/08/2026M1,600 (1) (1)Common Stock1,600$019,624(3)D
Stock Options (Right to Buy)$4.96 (2) (2)Common Stock30,72030,720(3)D
Explanation of Responses:
1. Distribution of time-based service award.
2. Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years.
3. Reflects the 1-for-25 reverse stock split effected by the Issuer on December 17, 2025.
/s/ George Ng, by John J. Wolfel, as Attorney-in-Fact08/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)